These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6307183)

  • 1. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].
    Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
    Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased disappearance rate of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) from the blood and its unresponsiveness to tocophreyl nicotinate and indomethacin in patients with primary hepatocellular carcinoma.
    Hobara N; Watanabe A
    Acta Med Okayama; 1979 Oct; 33(5):389-93. PubMed ID: 229696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood level of 5-fluorouracil (5-FU) by oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and tegafur in patients with hepatocellular carcinoma].
    Onji M; Kondo H; Yamashita Y; Ohta Y; Mori K; Fuse M
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2063-72. PubMed ID: 3005446
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum concentration of 5-FU and tegafur (FT-207) after administration of tegafur (FT-207) suppository with the colostomy].
    Kimoto M; Nagano H; Gunge N; Murei T; Iwamoto S; Seo Y; Yamamoto Y; Sano K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2853-8. PubMed ID: 3116942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
    Suenaga M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas].
    Takada T; Yasuda H; Uchiyama K; Hasegawa H
    Gan To Kagaku Ryoho; 1985 May; 12(5):1088-93. PubMed ID: 3922311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Futraful therapy on liver cancer.
    Kurihara M; Shirakabe H; Izumi T; Miyasaka K; Ariyama J
    Clin Oncol; 1977 Mar; 3(1):33-49. PubMed ID: 193664
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
    Une Y; Ito Y; Ogasawara K; Nagafuchi E; Matsuoka S; Misawa K; Sato N; Nakajima Y; Uchino J
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3153-9. PubMed ID: 2551251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical investigation of the combination therapy of 1-(2-tetrahydrofuryl)-5-fluorouracil (FH) fine granules and 5-FU dry syrup].
    Nakazawa I; Goto Y; Ouchi E; Nomura N; Suzuki N; Kikuchi T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):722-5. PubMed ID: 6820906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of orally and rectally administered Tegafur in liver metastases from gastric carcinoma.
    Reyes JM; Okazaki N; Yoshino M; Yoshida T
    Jpn J Clin Oncol; 1984 Mar; 14(1):41-7. PubMed ID: 6423866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [UFT concentration in various tissues from cancer patients].
    Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum and tissue concentration of tegafur and 5-FU after administration of tegafur suppository in patients with lung cancer--correcting the influence of residual blood in the tissue].
    Ohno K; Nakahara K; Hashimoto J; Matsumura A; Mizuta T; Akashi A; Nakagawa K; Takeda S; Minami M; Kawashima Y
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3603-8. PubMed ID: 2510605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
    Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on UFT concentration in tissues and serum of patients with malignant gynecologic tumors following oral administration].
    Ueda T; Kamiwatari M; Kosya S; Yamamoto S; Shiokawa H; Yamada E; Nagata Y
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2316-20. PubMed ID: 3111383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of tegafur encapsulated with slow-releasing granules (SF-SP) for patients with cancer of the digestive organs].
    Kameda C; Tanaka T; Shiomi M; Saka M; Katsu K; Itoh S
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2526-30. PubMed ID: 6439120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial on the effect of tegafur (SF-SP)].
    Futatsuki K; Shimada S; Kanda Y; Ishibashi I; Sendai H; Akazawa S; Hattori M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1112-5. PubMed ID: 6326685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of long-term administration of oral anti-cancer agent].
    Watanabe H; Sakakibara N
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):637-42. PubMed ID: 8470922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.